Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,762 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer.
Korkola JE, Collisson EA, Heiser M, Oates C, Bayani N, Itani S, Esch A, Thompson W, Griffith OL, Wang NJ, Kuo WL, Cooper B, Billig J, Ziyad S, Hung JL, Jakkula L, Feiler H, Lu Y, Mills GB, Spellman PT, Tomlin C, Mukherjee S, Gray JW. Korkola JE, et al. Among authors: thompson w. PLoS One. 2015 Jul 16;10(7):e0133219. doi: 10.1371/journal.pone.0133219. eCollection 2015. PLoS One. 2015. PMID: 26181325 Free PMC article.
Correction: Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer.
Korkola JE, Collisson EA, Heiser LM, Oates C, Bayani N, Itani S, Esch A, Thompson W, Griffith OL, Wang NJ, Kuo WL, Cooper B, Billig J, Ziyad S, Hung JL, Jakkula L, Feiler H, Lu Y, Mills GB, Spellman PT, Tomlin C, Mukherjee S, Gray JW. Korkola JE, et al. Among authors: thompson w. PLoS One. 2017 Oct 11;12(10):e0186551. doi: 10.1371/journal.pone.0186551. eCollection 2017. PLoS One. 2017. PMID: 29020035 Free PMC article.
Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes.
Watson SS, Dane M, Chin K, Tatarova Z, Liu M, Liby T, Thompson W, Smith R, Nederlof M, Bucher E, Kilburn D, Whitman M, Sudar D, Mills GB, Heiser LM, Jonas O, Gray JW, Korkola JE. Watson SS, et al. Among authors: thompson w. Cell Syst. 2018 Mar 28;6(3):329-342.e6. doi: 10.1016/j.cels.2018.02.001. Epub 2018 Mar 14. Cell Syst. 2018. PMID: 29550255 Free PMC article.
Sensitivity to targeted therapy differs between HER2-amplified breast cancer cells harboring kinase and helical domain mutations in PIK3CA.
Garay JP, Smith R, Devlin K, Hollern DP, Liby T, Liu M, Boddapati S, Watson SS, Esch A, Zheng T, Thompson W, Babcock D, Kwon S, Chin K, Heiser L, Gray JW, Korkola JE. Garay JP, et al. Among authors: thompson w. Breast Cancer Res. 2021 Aug 3;23(1):81. doi: 10.1186/s13058-021-01457-0. Breast Cancer Res. 2021. PMID: 34344439 Free PMC article.
Impact of resistance training on cardiometabolic health-related indices in patients with type 2 diabetes and overweight/obesity: a systematic review and meta-analysis of randomised controlled trials.
Al-Mhanna SB, Franklin BA, Jakicic JM, Stamatakis E, Pescatello LS, Riebe D, Thompson WR, Skinner J, Colberg SR, Alkhamees NH, Bin Sheeha B, Gülü M, Alghannam AF, Batrakoulis A. Al-Mhanna SB, et al. Among authors: thompson wr. Br J Sports Med. 2025 Jan 7:bjsports-2024-108947. doi: 10.1136/bjsports-2024-108947. Online ahead of print. Br J Sports Med. 2025. PMID: 39773835
Responsible research in health disparities using the Adolescent Brain Cognitive DevelopmentSM (ABCD) study.
Gonzalez MR, Cardenas-Iniguez C, Linares DE, Wonnum S, Bagot K, White EJ, Cuan A, DiMatteo S, Akiel YD, Lindsley P, Harris JC, Perez-Amparan E, Powell TD, Latino de City Heights Colch CO, Dowling G, Alkire D, Thompson WK, Murray TM. Gonzalez MR, et al. Among authors: thompson wk. Dev Cogn Neurosci. 2024 Dec 18;71:101497. doi: 10.1016/j.dcn.2024.101497. Online ahead of print. Dev Cogn Neurosci. 2024. PMID: 39724816 Free PMC article.
3,762 results